ASN NEURO最新文献

{"title":"Hippocampus Insulin Receptors Regulate Episodic and Spatial Memory Through Excitatory/Inhibitory Balance.","authors":"Cai-Yan Xue, Tian Gao, E Mao, Zhen-Zhen Kou, Ling Dong, Feng Gao","doi":"10.1177/17590914231206657","DOIUrl":"10.1177/17590914231206657","url":null,"abstract":"<p><p>It is well known that the hippocampus is a vital brain region playing a key role in both episodic and spatial memory. Insulin receptors (InsRs) are densely distributed in the hippocampus and are important for its function. However, the effects of InsRs on the function of the specific hippocampal cell types remain elusive. In this study, hippocampal InsRs knockout mice had impaired episodic and spatial memory. GABAergic neurons and glutamatergic neurons in the hippocampus are involved in the balance between excitatory and inhibitory (E/I) states and participate in the processes of episodic and spatial memory. InsRs are located mainly at excitatory neurons in the hippocampus, whereas 8.5% of InsRs are glutamic acid decarboxylase 2 (GAD2)::Ai9-positive (GABAergic) neurons. Next, we constructed a transgenic mouse system in which InsR expression was deleted from GABAergic (glutamate decarboxylase 2::InsR^fl/fl, GAD2^Cre::InsR^fl/fl) or glutamatergic neurons (vesicular glutamate transporter 2::InsR^fl/fl,Vglut2^Cre::InsR^fl/fl). Our results showed that in comparison to the InsR^fl/fl mice, both episodic and spatial memory were lower in GAD2^Cre::InsR^fl/fl and Vglut2^Cre::InsR^fl/fl. In addition, both GAD2^Cre::InsR^fl/fl and Vglut2^Cre::InsR^fl/fl were associated with more anxiety and lower glucose tolerance. These findings reveal that hippocampal InsRs might be crucial for episodic and spatial memory through E/I balance hippocampal regulation.</p>","PeriodicalId":8616,"journal":{"name":"ASN NEURO","volume":"15 ","pages":"17590914231206657"},"PeriodicalIF":4.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621302/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71420255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Upregulated DNA Damage-Linked Biomarkers in Parkinson's Disease Model Mice.","authors":"Fei Zeng, Karsten Parker, Yanqiang Zhan, Matthew Miller, Meng-Yang Zhu","doi":"10.1177/17590914231152099","DOIUrl":"10.1177/17590914231152099","url":null,"abstract":"<p><strong>Summary statement: </strong>The present study examined expression of DNA damage markers in VMAT2 Lo PD model mice. The results demonstrate there is a significant increase in these DNA damage markers mostly in the brain regions of 18- and 23-month-old model mice, indicating oxidative stress-induced DNA lesion is an important pathologic feature of this mouse model.</p>","PeriodicalId":8616,"journal":{"name":"ASN NEURO","volume":"15 ","pages":"17590914231152099"},"PeriodicalIF":4.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2c/ad/10.1177_17590914231152099.PMC9880594.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10784089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Advancements in a FRET Biosensor for Live-Cell Fluorescence-Lifetime High-Throughput Screening of Alpha-Synuclein.","authors":"Anthony R Braun, Noah Nathan Kochen, Samantha L Yuen, Elly E Liao, Razvan L Cornea, David D Thomas, Jonathan N Sachs","doi":"10.1177/17590914231184086","DOIUrl":"10.1177/17590914231184086","url":null,"abstract":"<p><p>There is a critical need for small molecules capable of rescuing pathophysiological phenotypes induced by alpha-synuclein (aSyn) misfolding and oligomerization. Building upon our previous aSyn cellular fluorescence lifetime (FLT)-Förster resonance energy transfer (FRET) biosensors, we have developed an inducible cell model incorporating the red-shifted mCyRFP1/mMaroon1 (OFP/MFP) FRET pair. This new aSyn FRET biosensor improves the signal-to-noise ratio, reduces nonspecific background FRET, and results in a 4-fold increase (transient transfection) and 2-fold increase (stable, inducible cell lines) in FRET signal relative to our previous GFP/RFP aSyn biosensors. The inducible system institutes greater temporal control and scalability, allowing for fine-tuning of biosensor expression and minimizes cellular cytotoxicity due to overexpression of aSyn. Using these inducible aSyn-OFP/MFP biosensors, we screened the Selleck library of 2684 commercially available, FDA-approved compounds and identified proanthocyanidins and casanthranol as novel hits. Secondary assays validated the ability of these compounds to modulate aSyn FLT-FRET. Functional assays probing cellular cytotoxicity and aSyn fibrillization demonstrated their capability to inhibit seeded aSyn fibrillization. Proanthocyanidins completely rescued aSyn fibril-induced cellular toxicity with EC₅₀ of 200 nM and casanthranol supported a 85.5% rescue with a projected EC₅₀ of 34.2 μM. Furthermore, proanthocyanidins provide a valuable tool compound to validate our aSyn biosensor performance in future high-throughput screening campaigns of industrial-scale (million-compound) chemical libraries.</p>","PeriodicalId":8616,"journal":{"name":"ASN NEURO","volume":"15 ","pages":"17590914231184086"},"PeriodicalIF":3.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/04/09/10.1177_17590914231184086.PMC10338669.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10169777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diazepam Binding Inhibitor Control of Eu- and Hypoglycemic Patterns of Ventromedial Hypothalamic Nucleus Glucose-Regulatory Signaling.","authors":"Sagor C Roy, Subash Sapkota, Madhu Babu Pasula, Khaggeswar Bheemanapally, Karen P Briski","doi":"10.1177/17590914231214116","DOIUrl":"10.1177/17590914231214116","url":null,"abstract":"<p><p>Pharmacological stimulation/antagonism of astrocyte glio-peptide octadecaneuropeptide signaling alters ventromedial hypothalamic nucleus (VMN) counterregulatory γ-aminobutyric acid (GABA) and nitric oxide transmission. The current research used newly developed capillary zone electrophoresis-mass spectrometry methods to investigate hypoglycemia effects on VMN octadecaneuropeptide content, along with gene knockdown tools to determine if octadecaneuropeptide signaling regulates these transmitters during eu- and/or hypoglycemia. Hypoglycemia caused dissimilar adjustments in the octadecaneuropeptide precursor, i.e., diazepam-binding-inhibitor and octadecaneuropeptide levels in dorsomedial versus ventrolateral VMN. Intra-VMN diazepam-binding-inhibitor siRNA administration decreased baseline 67 and 65 kDa glutamate decarboxylase mRNA levels in GABAergic neurons laser-microdissected from each location, but only affected hypoglycemic transcript expression in ventrolateral VMN. This knockdown therapy imposed dissimilar effects on eu- and hypoglycemic glucokinase and 5'-AMP-activated protein kinase-alpha1 (AMPKα1) and -alpha2 (AMPKα2) gene profiles in dorsomedial versus ventrolateral GABAergic neurons. Diazepam-binding-inhibitor gene silencing up-regulated baseline (dorsomedial) or hypoglycemic (ventrolateral) nitrergic neuron neuronal nitric oxide synthase mRNA profiles. Baseline nitrergic cell glucokinase mRNA was up- (ventrolateral) or down- (dorsomedial) regulated by diazepam-binding-inhibitor siRNA, but knockdown enhanced hypoglycemic profiles in both sites. Nitrergic nerve cell AMPKα1 and -α2 transcripts exhibited division-specific responses to this genetic manipulation during eu- and hypoglycemia. Results document the utility of capillary zone electrophoresis-mass spectrometric tools for quantification of ODN in small-volume brain tissue samples. Data show that hypoglycemia has dissimilar effects on ODN signaling in the two major neuroanatomical divisions of the VMN and that this glio-peptide imposes differential control of glucose-regulatory neurotransmission in the VMNdm versus VMNvl during eu- and hypoglycemia.</p>","PeriodicalId":8616,"journal":{"name":"ASN NEURO","volume":"15 ","pages":"17590914231214116"},"PeriodicalIF":4.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687944/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138457577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"SOD1^G93A Astrocyte-Derived Extracellular Vesicles Induce Motor Neuron Death by a miRNA-155-5p-Mediated Mechanism.","authors":"Soledad Marton, Ernesto Miquel, Joaquín Acosta-Rodríguez, Santiago Fontenla, Gabriela Libisch, Patricia Cassina","doi":"10.1177/17590914231197527","DOIUrl":"10.1177/17590914231197527","url":null,"abstract":"<p><p>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by upper and lower motor neuron (MN) degeneration. Astrocytes surrounding MNs are known to modulate ALS progression. When cocultured with astrocytes overexpressing the ALS-linked mutant Cu/Zn superoxide dismutase (SOD1^G93A) or when cultured with conditioned medium from SOD1^G93A astrocytes, MN survival is reduced. The exact mechanism of this neurotoxic effect is unknown. Astrocytes secrete extracellular vesicles (EVs) that transport protein, mRNA, and microRNA species from one cell to another. The size and protein markers characteristic of exosomes were observed in the EVs obtained from cultured astrocytes, indicating their abundance in exosomes. Here, we analyzed the microRNA content of the exosomes derived from SOD1^G93A astrocytes and evaluated their role in MN survival. Purified MNs exposed to SOD1^G93A astrocyte-derived exosomes showed reduced survival and neurite length compared to those exposed to exosomes derived from non-transgenic (non-Tg) astrocytes. Analysis of the miRNA content of the exosomes revealed that miR-155-5p and miR-582-3p are differentially expressed in SOD1^G93A exosomes compared with exosomes from non-Tg astrocytes. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis indicates that miR-155-5p and miR-582-3p predicted targets are enriched in the neurotrophin signaling pathway. Importantly, when levels of miR-155-5p were reduced by incubation with a specific antagomir, SOD1^G93A exosomes did not affect MN survival or neurite length. These results demonstrate that SOD1^G93A-derived exosomes are sufficient to induce MN death, and miRNA-155-5p contributes to this effect. miRNA-155-5p may offer a new therapeutic target to modulate disease progression in ALS.</p>","PeriodicalId":8616,"journal":{"name":"ASN NEURO","volume":"15 ","pages":"17590914231197527"},"PeriodicalIF":4.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a0/10/10.1177_17590914231197527.PMC10467309.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10126979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Polymorphisms in <i>TPT1</i> Pathways in Pediatric Astrocytomas.","authors":"Eduardo Morais de Castro,&nbsp;Leonardo Vinícius Barbosa,&nbsp;Aline Simoneti Fonseca,&nbsp;Seigo Nagashima,&nbsp;Caroline Busatta Vaz de Paula,&nbsp;Rafaela Zeni,&nbsp;Letícia Arianne Panini do Carmo,&nbsp;Luciane R Cavalli,&nbsp;Luiz Fernando Bleggi Torres,&nbsp;Andrea Senff Ribeiro,&nbsp;Lucia de Noronha,&nbsp;Cleber Machado-Souza","doi":"10.1177/17590914231153481","DOIUrl":"https://doi.org/10.1177/17590914231153481","url":null,"abstract":"<p><p>Central nervous system tumors, especially astrocytomas, are the solid neoplasms with the highest incidence and mortality rates in childhood. The diagnosis is based on histopathological characteristics, but molecular methods have been increasingly used. Translationally controlled tumor protein (TCTP) protein, encoded by the tumor protein, translationally controlled 1 (<i>TPT1</i>) gene, is a multifunctional protein with an important physiological role in the cell cycle. Expression of this protein has been associated with several neoplasms, including astrocytomas in adults. However, the role of this protein in pediatric astrocytomas is largely unknown. We aim to evaluate in cases of pediatric astrocytomas, the frequency of polymorphisms in the <i>TPT1</i> gene and other genes associated with its molecular pathways, such as <i>MTOR</i>, <i>MDM2</i>, <i>TP53</i>, and <i>CDKN1A</i>, correlating it with protein expression and clinical variables, in formalin-fixed, paraffin-embedded (FFPE) samples. These samples were submitted to genotyping and immunohistochemistry analyses. The most revealing results refer to the <i>MDM2</i> gene, rs117039649 [G/C], in which C polymorphic allele was observed only in the glioblastomas (<i>p </i>= .028). The <i>CDKN1A</i> gene, rs3176334 [T/C] presented a homozygous polymorphic genotype only in high-grade astrocytomas, when infiltrating tumors were compared (<i>p </i>= .039). The immunohistochemical expression of cytoplasmic MDM2 correlated with better survival rates in patients with glioblastoma (<i>p = </i>.018). The presence of polymorphisms in the <i>MDM2</i> and <i>CDKN1A</i> genes, as well as a specific correlation between MDM2 expression, suggests a likely association with risk in pediatric astrocytomas. This study sought the probable role involved in the TCTP pathway, and associated proteins, in the tumorigenesis of pediatric astrocytomas, and some could have potential impact as prognostic markers in these patients.</p>","PeriodicalId":8616,"journal":{"name":"ASN NEURO","volume":"15 ","pages":"17590914231153481"},"PeriodicalIF":4.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/65/32/10.1177_17590914231153481.PMC9903018.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10725456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"In Memoriam, Dr. Robert K. Yu.","authors":"Thomas N Seyfried,&nbsp;Yutaka Itokazu,&nbsp;Toshio Ariga,&nbsp;Erhard Bieberich","doi":"10.1177/17590914221146888","DOIUrl":"https://doi.org/10.1177/17590914221146888","url":null,"abstract":"Dr. Robert K. Yu, affectionately known to most of his friends and colleagues as “Bob,” passed away peacefully on May 18, 2022, at the age of 84. Bob served as President of the American Society of Neurochemistry (ASN) from 2001 to 2003 where he instituted a number of foundational changes that improved membership and strengthened financial solvency (Figure 1). Bob received his BS in Chemistry from Tunghai University, Taiwan, in 1960. He received his PhD in Biochemistry from the University of Illinois Urbana/ Champaign in 1967 under the mentorship of Dr. Herbert E. Carter, a member of the National Academy of Sciences. Bob followed in the footsteps of his beloved and accomplished mother, Dr. June Yu, who graduated from the University of Illinois Urbana/Champaign with a PhD in Chemistry and was a pioneer as the first Chinese woman to receive a PhD in Chemistry in the US. Bob completed postdoctoral training in the Department of Neurology at the Albert Einstein College of Medicine/Yeshiva University from 1967 to 1972 under the mentorship of Dr. Robert W. Ledeen, a long-standing member of ASN. Bob began his long and distinguished scientific career as an Assistant Professor in the Departments of Neurology and Molecular Biology and Biochemistry at Yale University in 1973. Bob was rapidly promoted to tenured Professor where he worked until 1988. Bob received a Med. Sci. D. honorary degree from the University of Tokyo in 1980 and an M.A.H. honorary degree from Yale University in 1985. Bob was recruited as Chair and Professor of the Department of Biochemistry and Molecular Biophysics at the Medical College of Virginia/Virginia Commonwealth University. In 2000, Bob was recruited as Director and Professor of the Institute of Molecular Medicine and Genetics at the Medical College of Georgia and served in that capacity until 2009. He also served as President of the Society of Chinese Bioscientists in America from 2008 to 2010. He held the Chair of Georgia Research Alliance Eminent Scholar in Molecular and Cellular Neurobiology, and was the Founding Director of the Institute of Neuroscience at Georgia Health Sciences University, now Augusta University, until his death. Bob’s major research interests were in neurochemistry and developmental neurobiology, particularly as related to glcoconjugates in health and diseases. He published over 400 peer-reviewed scientific papers and served as a senior editor in several high-profile scientific journals including Journal of Lipid Research, Journal of Biological Chemistry, and ASN Neuro. Bob was widely regarded as a leader in the field of glycosphingolipid research. He widely supported the expansion of the Japan Oil Chemists’ Society. For over 40 years, he and his research teams characterized numerous glycosphingolipid structures and elucidated their biophysical properties, biosynthetic pathways, and biological functions. Bob and Dr. Robert Ledeen were the first to demonstrate that the naturally occurring sialidase-susceptib","PeriodicalId":8616,"journal":{"name":"ASN NEURO","volume":"15 ","pages":"17590914221146888"},"PeriodicalIF":4.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f7/68/10.1177_17590914221146888.PMC9841836.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9190293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Sex and APOE Genotype Alter the Basal and Induced Inflammatory States of Primary Astrocytes from Humanized Targeted Replacement Mice.","authors":"Isha Mhatre-Winters,&nbsp;Aseel Eid,&nbsp;Yoonhee Han,&nbsp;Kim Tieu,&nbsp;Jason R Richardson","doi":"10.1177/17590914221144549","DOIUrl":"https://doi.org/10.1177/17590914221144549","url":null,"abstract":"<p><p>Apolipoprotein E4 (APOE4) genotype and sex are significant risk factors for Alzheimer's disease (AD), with females demonstrating increased risk modulated by APOE genotype. APOE is predominantly expressed in astrocytes, however, there is a lack of comprehensive assessments of sex differences in astrocytes stratified by APOE genotype. Here, we examined the response of mixed-sex and sex-specific neonatal APOE3 and APOE4 primary mouse astrocytes (PMA) to a cytokine mix of IL1b, TNFa, and IFNg. Pro-inflammatory and anti-inflammatory cytokine profiles were assessed by qRT-PCR and Meso Scale Discovery multiplex assay. Mixed-sex APOE4 PMA were found to have higher basal messenger RNA expression of several pro-inflammatory cytokines including <i>Il6</i>, <i>Tnfa</i>, <i>Il1b</i>, <i>Mcp1</i>, <i>Mip1a</i>, and <i>Nos2</i> compared to APOE3 PMA, which was accompanied by increased levels of these secreted cytokines. In sex-specific cultures, basal expression of <i>Il1b</i>, <i>Il6</i>, and <i>Nos2</i> was 1.5 to 2.5 fold higher in APOE4 female PMA compared to APOE4 males, with both being higher than APOE3 PMA. Similar results were found for secreted levels of these cytokines. Together, these findings indicate that APOE4 genotype and female sex, contribute to a greater inflammatory response in primary astrocytes and these data may provide a framework for investigating the mechanisms contributing to genotype and sex differences in AD-related neuroinflammation.</p>","PeriodicalId":8616,"journal":{"name":"ASN NEURO","volume":"15 ","pages":"17590914221144549"},"PeriodicalIF":4.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/28/06/10.1177_17590914221144549.PMC9982390.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9926145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Thioredoxin-1 Promotes Mitochondrial Biogenesis Through Regulating AMPK/Sirt1/PGC1α Pathway in Alzheimer's Disease.","authors":"Jinjing Jia,&nbsp;Jiayi Yin,&nbsp;Yu Zhang,&nbsp;Guangtao Xu,&nbsp;Min Wang,&nbsp;Haiying Jiang,&nbsp;Li Li,&nbsp;Xiansi Zeng,&nbsp;Dongsheng Zhu","doi":"10.1177/17590914231159226","DOIUrl":"https://doi.org/10.1177/17590914231159226","url":null,"abstract":"<p><p>Alzheimer's disease (AD) is the most common neurodegenerative disease. Increasing studies suggest that mitochondrial dysfunction is closely related to the pathogenesis of AD. Thioredoxin-1 (Trx-1), one of the major redox proteins in mammalian cells, plays neuroprotection in AD. However, whether Trx-1 could regulate the mitochondrial biogenesis in AD is largely unknown. In the present study, we found that Aβ_25-35 treatment not only markedly induced excessive production of reactive oxygen species and apoptosis, but also significantly decreased the number of mitochondria with biological activity and the adenosine triphosphate content in mitochondria, suggesting mitochondrial biogenesis was impaired in AD cells. These changes were reversed by Lentivirus-mediated stable overexpression of Trx-1 or exogenous administration of recombinant human Trx-1. What's more, adeno-associated virus-mediated specific overexpression of Trx-1 in the hippocampus of β-amyloid precursor protein/presenilin 1 (APP/PS1) mice ameliorated the learning and memory and attenuated hippocampal Aβ deposition. Importantly, overexpression of Trx-1 in APP/PS1 mice restored the decrease in mitochondrial biogenesis-associated proteins, including adenosine monophosphate -activated protein kinase (AMPK), silent information regulator factor 2-related enzyme 1 (Sirt1) and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α). In addition, Lentivirus-mediated overexpression of Trx-1 in rat adrenal pheochromocytoma (PC12) cells also restored the decrease of AMPK, Sirt1, and PGC1α by Aβ_25-35 treatment. Pharmacological inhibition of AMPK activity significantly abolished the effect of Trx-1 on mitochondrial biogenesis. Taken together, our data provide evidence that Trx-1 promoted mitochondrial biogenesis via restoring AMPK/Sirt1/PGC1α pathway in AD.</p>","PeriodicalId":8616,"journal":{"name":"ASN NEURO","volume":"15 ","pages":"17590914231159226"},"PeriodicalIF":4.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b4/d8/10.1177_17590914231159226.PMC9969465.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10800043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"An Association of Chitinase-3 Like-Protein-1 With Neuronal Deterioration in Multiple Sclerosis.","authors":"Intakhar Ahmad, Stig Wergeland, Eystein Oveland, Lars Bø","doi":"10.1177/17590914231198980","DOIUrl":"10.1177/17590914231198980","url":null,"abstract":"<p><p>Elevated levels of Chitinase-3-like protein-1 (CHI3L1) in cerebrospinal fluid have previously been linked to inflammatory activity and disease progression in multiple sclerosis (MS) patients. This study aimed to investigate the presence of CHI3L1 in the brains of MS patients and in the cuprizone model in mice (CPZ), a model of toxic/metabolic demyelination and remyelination in different brain areas. In MS gray matter (GM), CHI3L1 was detected primarily in astrocytes and in a subset of pyramidal neurons. In neurons, CHI3L1 immunopositivity was associated with lipofuscin-like substance accumulation, a sign of cellular aging that can lead to cell death. The density of CHI3L1-positive neurons was found to be significantly higher in normal-appearing MS GM tissue compared to that of control subjects (<i>p</i>  =  .014). In MS white matter (WM), CHI3L1 was detected in astrocytes located within lesion areas, as well as in perivascular normal-appearing areas and in phagocytic cells from the initial phases of lesion development. In the CPZ model, the density of CHI3L1-positive cells was strongly associated with microglial activation in the WM and choroid plexus inflammation. Compared to controls, CHI3L1 immunopositivity in WM was increased from an early phase of CPZ exposure. In the GM, CHI3L1 immunopositivity increased later in the CPZ exposure phase, particularly in the deep GM region. These results indicate that CHI3L1 is associated with neuronal deterioration, pre-lesion pathology, along with inflammation in MS.</p>","PeriodicalId":8616,"journal":{"name":"ASN NEURO","volume":"15 ","pages":"17590914231198980"},"PeriodicalIF":4.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10710113/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138795761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}